Skip to main content


Fig. 1 | Molecular Cancer

Fig. 1

From: Recent updates on CAR T clinical trials for multiple myeloma

Fig. 1

The schematic diagram of representative structures of BCMA-targeted chimeric antigen receptors (CAR). The BCMA CARs contain a single-chain of BCMA antibody variable fragment (ScFv), a transmembrane domain, a hinge region, a co-stimulation domain (4-1BB, CD28 or OX40), and a CD3z domain. Additional sequences (such as PI3K inhibitor) are added to enhance identification of CAR+ T cells. LCAR-B38M CAR contains two epitopes of BCMA ScFv, VHH1 and VHH2. PI3K: phosphoinositol 3 kinase

Back to article page